CD84 is a survival receptor for CLL cells - Binsky-Ehrenreich, I; Marom, A; Sobotta, M C; Shvidel, L; Berrebi, A; Hazan-Halevy, I; Kay, S; Aloshin, A; Sagi, I; Goldenberg, D M; Leng, L; Bucala, R; et al. (Oncogene, 2014)
Keywords: 631/80/86; 692/420/755; 692/699/67/1990/283/1895; Analysis; Antigens, CD - physiology; Antigens, Differentiation, B-Lymphocyte - immunology; Apoptosis; Base Sequence; Bcl-2 protein; Bone marrow; Case-Control Studies; CD5 antigen; Cell activation; Cell Biology; Cell death; Cell Line, Tumor; Cell surface; Cell Survival; Chronic lymphocytic leukemia; DNA Primers; Gene therapy; Genetic aspects; Health aspects; Histocompatibility Antigens Class II - immunology; Human Genetics; Humans; Internal Medicine; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell - immunology; Leukemia, Lymphocytic, Chronic, B-Cell - pathology; Leukocyte migration; Lymphatic leukemia; Lymphocyte receptors; Lymphocytes B; Macrophage migration inhibitory factor; Mcl-1 protein; Medicine; Medicine & Public Health; mRNA; Oncology; original-article; Peripheral blood; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Risk factors; Signaling Lymphocytic Activation Molecule Family; Survival analysis; T cells; Israel; CD74; apoptosis; CD84; MIF; survival